Lexaria Price Sales Ratio from 2010 to 2025

LEXXW Stock  USD 0.25  0.05  25.00%   
Lexaria Bioscience Price Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price Sales Ratio is likely to outpace its year average in 2025. During the period from 2010 to 2025, Lexaria Bioscience Price Sales Ratio regression line of quarterly data had mean square error of  10,781 and geometric mean of  116.72. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
104.94012449
Current Value
140.45
Quarterly Volatility
159.49352253
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 129 K, Interest Expense of 125.2 K or Other Operating Expenses of 7.5 M, as well as many indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0 or PTB Ratio of 57.61. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Lexaria Price Sales Ratio Regression Statistics

Arithmetic Mean181.89
Geometric Mean116.72
Coefficient Of Variation87.69
Mean Deviation138.35
Median137.90
Standard Deviation159.49
Sample Variance25,438
Range379
R-Value(0.78)
Mean Square Error10,781
R-Squared0.60
Significance0.0004
Slope(26.05)
Total Sum of Squares381,573

Lexaria Price Sales Ratio History

2025 140.45
2024 104.94
2023 104.29
2022 30.7
2021 68.21
2020 37.79
2019 32.31

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Price Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Sales Ratio 104.94  140.45 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.